|
Dear Fellow Investor,
Dylan here, I just wanted to follow up with you and make sure everything's good...
A moment ago, I sent you an email about a Biotech breakthrough.
Big Pharma loves to buy small biotech's right after the market drops.
When the market dropped 19% in the fourth quarter of 2018, Ex-Wall Street CEO Dylan Jovine picked 3 biotech stocks ripe
for a takeover.
On October 1st, 2018, he recommended Tesaro... 63 days later it was taken over for an easy 91% profit...
On October 19, 2018 he recommended Pacific Biosciences... 4 days later it was taken over for a quick 72% gain...
On January 4, 2019 he recommended Loxo Oncology... 3 days later it was taken over for a fast 71% gain...
In this
special letter,
you'll learn why Dylan thinks now is the best time to make money with this tiny stock.
You'll discover:
-
Why Big Pharma firms Allergan, Celgene and others have invested over $1 billion into this tiny biotech.
-
Why President Trump thinks this biotech's breakthrough is a matter of national security.
-
How a takeover could make you $41,250 in profits any day now.
That's because in
this letter,
we'll show you how get into this company right now - before it's too late!
You don't want to miss this.
Sincerely,
Brad Sullivan
Publisher
Behind the Markets
|
